ST. MARY MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $445K
- Transactions
- 60
- Companies
- 25
- Average per transaction
- $7,415
Who reported the payments
| Gilead | $296,780 |
| UCB SA | $52,051 |
| Janssen Research & Development, LLC | $35,054 |
| Stryker | $17,520 |
| Olympus America Inc. | $10,208 |
| Premia Spine, Ltd. | $8,270 |
| E.r. Squibb & Sons, L.L.C. | $7,500 |
| Merge Healthcare Incorporated | $4,161 |
| Biotronik Inc. | $1,934 |
| Foundation Medicine, Inc. | $1,681 |
| Medline Industries LP | $1,620 |
| Johnson & Johnson Surgical Vision, Inc. | $1,600 |
| Johnson & Johnson | $1,191 |
| Medical Device Business Services, Inc. | $1,000 |
| Hikma Pharmaceuticals USA | $908 |
| Linvatec Corporation | $690 |
| Livanova USA, Inc. | $596 |
| Welch Allyn | $505 |
| Zimmer Biomet | $396 |
| Recordati_rare_diseases_inc. | $300 |
| Clovis Oncology, Inc. | $275 |
| Abbott | $249 |
| Fisher Scientific Company L.L.C. | $192 |
| C. R. Bard, Inc. & Subsidiaries | $100 |
| Amgen | $96 |